Bookmark and Share
(4-(Hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl)(2-(methoxymethyl)piperidin-1-yl)methanone (CID 56593033) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(6)
 
 
Inactive(46)
 
 
Top Targets:
Hydrolase 4(8)
 
 
 
Peptidase S9(4)
 
 
Peptidase S9(4)
 
 
Abhydrolase 2(2)
 
 
BAAT C(2)
 
 
BioAssay Types:
Confirmatory(5)
 
 
 
BioActivity Types:
IC50(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 6    Data Row: 52   Total Pages: 2   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103913583]
IC50 0.000137Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based cell-based gel-based Activity-Based Protein Profiling (ABPP) IC50 for anti-target ABHD11 [AID504482, Type: confirmatory]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
2
[SID103913583]
IC50 0.001Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) IC50 for anti-target ABHD11 Set 2 [AID504507, Type: confirmatory]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
3
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_1, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
4
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_1, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
5
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520, Type: other]
View
6
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522, Type: other]
View
7
[SID103913583]
50Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds set 2 [AID504510_1, Type: confirmatory]
View
8
[SID103913583]
50Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds set 2 [AID504510_2, Type: confirmatory]
View
9
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_38, Type: other]platelet-activating factor acetylhydrolase isoform Ib beta subunit [Mus musculus] [gi:1373363]
View
10
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_14, Type: other]platelet-activating factor acetylhydrolase IB subunit gamma [Mus musculus] [gi:6679201]
View
11
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_6, Type: other]Prepl protein [Mus musculus] [gi:13435484]
View
12
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_3, Type: other]Acyl-CoA thioesterase 1 [Mus musculus] [gi:20380528]
View
13
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_39, Type: other]Ddhd1 protein [Mus musculus] [gi:27694042]
View
14
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_17, Type: other]isoamyl acetate-hydrolyzing esterase 1 homolog [Mus musculus] [gi:27754071]
View
15
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_31, Type: other]abhydrolase domain-containing protein 16A [Mus musculus] [gi:30519896]
View
16
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_24, Type: other]protein phosphatase methylesterase 1 [Mus musculus] [gi:30794138]
View
17
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_23, Type: other]Prcp protein [Mus musculus] [gi:32967631]
View
18
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_20, Type: other]Pnpla6 protein [Mus musculus] [gi:34784201]
View
19
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_21, Type: other]Pla2g6 protein [Mus musculus] [gi:34784362]
View
20
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_15, Type: other]Abhydrolase domain containing 10 [Mus musculus] [gi:37231537]
View
21
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_30, Type: other]Dipeptidylpeptidase 8 [Mus musculus] [gi:37590654]
View
22
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_5, Type: other]Acyl-CoA thioesterase 2 [Mus musculus] [gi:39992610]
View
23
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_12, Type: other]Arylacetamide deacetylase-like 1 [Mus musculus] [gi:52139053]
View
24
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_5, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
25
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_16, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
26
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_7, Type: other]Fam108b protein [Mus musculus] [gi:61403362]
View
27
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_3, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View
28
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_32, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View
29
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_11, Type: other]Patatin-like phospholipase domain containing 8 [Mus musculus] [gi:117558667]
View
30
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_4, Type: other]lysophospholipase 2 [Mus musculus] [gi:123122209]
View
31
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_37, Type: other]lysophospholipase 2 [Mus musculus] [gi:123122209]
View
32
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_13, Type: other]dipeptidylpeptidase 7 [Mus musculus] [gi:123227495]
View
33
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_4, Type: other]dipeptidylpeptidase 4 [Mus musculus] [gi:123233284]
View
34
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_9, Type: other]cathepsin A [Mus musculus] [gi:123240058]
View
35
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_10, Type: other]abhydrolase domain containing 12 [Mus musculus] [gi:123241061]
View
36
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_34, Type: other]fatty acid amide hydrolase [Mus musculus] [gi:123253900]
View
37
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_36, Type: other]fatty acid synthase [Mus musculus] [gi:123288587]
View
38
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_25, Type: other]acyl-CoA thioesterase 7 [Mus musculus] [gi:123857891]
View
39
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_28, Type: other]Serine hydrolase-like [Mus musculus] [gi:127797596]
View
40
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_29, Type: other]presenilin associated, rhomboid-like [Mus musculus] [gi:148665146]
View
41
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_22, Type: other]prolyl endopeptidase [Mus musculus] [gi:148673089]
View
42
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_27, Type: other]lysophospholipase 3, isoform CRA_a [Mus musculus] [gi:148679401]
View
43
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_33, Type: other]sialic acid acetylesterase [Mus musculus] [gi:148693491]
View
44
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_19, Type: other]lysosomal acid lipase 1 [Mus musculus] [gi:148709804]
View
45
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_26, Type: other]Lactamase, beta [Mus musculus] [gi:187955464]
View
46
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_2, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
47
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_8, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
48
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_35, Type: other]dipeptidyl peptidase 9 [Mus musculus] [gi:255003757]
View
49
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of diacylglycerol lipase, beta (DAGLb): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of overexpressed DAGLb in vitro; triazole urea library [AID602303, Type: other]sn1-specific diacylglycerol lipase beta [Mus musculus] [gi:31559956]
View
50
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_18, Type: other]Apeh protein, partial [Mus musculus] [gi:20072022]
View